Everest Medicines Ltd. has filed a Next Day Disclosure Return with the Hong Kong Stock Exchange, announcing the issuance of new shares. The company disclosed the allotment and issue of 143,305 new ordinary shares as part of its Post-IPO Share Option Scheme. The shares were issued at weighted average prices of HKD 22.54 and HKD 19.64491 per share on July 11 and July 14, 2025, respectively.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.